
### [MONDO:0019822](http://purl.obolibrary.org/obo/MONDO_0019822)
**Label:** arterial duct anomaly

**Subclasses:** [MONDO:0008209](http://purl.obolibrary.org/obo/MONDO_0008209) (Char syndrome), [MONDO:0019823](http://purl.obolibrary.org/obo/MONDO_0019823) (premature closure of the arterial duct), [MONDO:0011827](http://purl.obolibrary.org/obo/MONDO_0011827) (patent ductus arteriosus), [MONDO:0014879](http://purl.obolibrary.org/obo/MONDO_0014879) (patent ductus arteriosus 3; PDA3), [MONDO:0020412](http://purl.obolibrary.org/obo/MONDO_0020412) (congenital patent ductus arteriosus aneurysm), [MONDO:0018758](http://purl.obolibrary.org/obo/MONDO_0018758) (familial patent arterial duct), [MONDO:0014878](http://purl.obolibrary.org/obo/MONDO_0014878) (patent ductus arteriosus 2; PDA2), 

**Mapped go classes:** [GO:0003091](http://purl.obolibrary.org/obo/GO_0003091) (renal water homeostasis), [GO:0000979](http://purl.obolibrary.org/obo/GO_0000979) (RNA polymerase II core promoter sequence-specific DNA binding), [GO:0000977](http://purl.obolibrary.org/obo/GO_0000977) (RNA polymerase II regulatory region sequence-specific DNA binding), [GO:0006366](http://purl.obolibrary.org/obo/GO_0006366) (transcription by RNA polymerase II), [GO:0045444](http://purl.obolibrary.org/obo/GO_0045444) (fat cell differentiation), [GO:0001106](http://purl.obolibrary.org/obo/GO_0001106) (RNA polymerase II transcription corepressor activity), [GO:0001105](http://purl.obolibrary.org/obo/GO_0001105) (RNA polymerase II transcription coactivator activity), [GO:0006006](http://purl.obolibrary.org/obo/GO_0006006) (glucose metabolic process), [GO:0043027](http://purl.obolibrary.org/obo/GO_0043027) (cysteine-type endopeptidase inhibitor activity involved in apoptotic process), [GO:0043588](http://purl.obolibrary.org/obo/GO_0043588) (skin development), [GO:0048485](http://purl.obolibrary.org/obo/GO_0048485) (sympathetic nervous system development), [GO:0050796](http://purl.obolibrary.org/obo/GO_0050796) (regulation of insulin secretion), [GO:0001077](http://purl.obolibrary.org/obo/GO_0001077) (transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0045892](http://purl.obolibrary.org/obo/GO_0045892) (negative regulation of transcription, DNA-templated), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0001822](http://purl.obolibrary.org/obo/GO_0001822) (kidney development), [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity), [GO:0055062](http://purl.obolibrary.org/obo/GO_0055062) (phosphate ion homeostasis), [GO:0046983](http://purl.obolibrary.org/obo/GO_0046983) (protein dimerization activity), [GO:0000983](http://purl.obolibrary.org/obo/GO_0000983) (transcription factor activity, RNA polymerase II core promoter sequence-specific DNA binding), [GO:0001158](http://purl.obolibrary.org/obo/GO_0001158) (enhancer sequence-specific DNA binding), [GO:0007423](http://purl.obolibrary.org/obo/GO_0007423) (sensory organ development), [GO:0000981](http://purl.obolibrary.org/obo/GO_0000981) (RNA polymerase II transcription factor activity, sequence-specific DNA binding), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0035909](http://purl.obolibrary.org/obo/GO_0035909) (aorta morphogenesis), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0042593](http://purl.obolibrary.org/obo/GO_0042593) (glucose homeostasis), [GO:0072210](http://purl.obolibrary.org/obo/GO_0072210) (metanephric nephron development), [GO:0072017](http://purl.obolibrary.org/obo/GO_0072017) (distal tubule development), [GO:0051216](http://purl.obolibrary.org/obo/GO_0051216) (cartilage development), [GO:0055074](http://purl.obolibrary.org/obo/GO_0055074) (calcium ion homeostasis), [GO:0055075](http://purl.obolibrary.org/obo/GO_0055075) (potassium ion homeostasis), [GO:0008285](http://purl.obolibrary.org/obo/GO_0008285) (negative regulation of cell proliferation), [GO:0008284](http://purl.obolibrary.org/obo/GO_0008284) (positive regulation of cell proliferation), [GO:0055078](http://purl.obolibrary.org/obo/GO_0055078) (sodium ion homeostasis), [GO:0097070](http://purl.obolibrary.org/obo/GO_0097070) (ductus arteriosus closure), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0043525](http://purl.obolibrary.org/obo/GO_0043525) (positive regulation of neuron apoptotic process), [GO:0043524](http://purl.obolibrary.org/obo/GO_0043524) (negative regulation of neuron apoptotic process), [GO:0072044](http://purl.obolibrary.org/obo/GO_0072044) (collecting duct development), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0045595](http://purl.obolibrary.org/obo/GO_0045595) (regulation of cell differentiation), [GO:0035136](http://purl.obolibrary.org/obo/GO_0035136) (forelimb morphogenesis), [GO:0035137](http://purl.obolibrary.org/obo/GO_0035137) (hindlimb morphogenesis), [GO:0035810](http://purl.obolibrary.org/obo/GO_0035810) (positive regulation of urine volume), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0003682](http://purl.obolibrary.org/obo/GO_0003682) (chromatin binding), [GO:0042127](http://purl.obolibrary.org/obo/GO_0042127) (regulation of cell proliferation), [GO:0097276](http://purl.obolibrary.org/obo/GO_0097276) (cellular creatinine homeostasis), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0097275](http://purl.obolibrary.org/obo/GO_0097275) (cellular ammonia homeostasis), [GO:0097277](http://purl.obolibrary.org/obo/GO_0097277) (cellular urea homeostasis), [GO:0003713](http://purl.obolibrary.org/obo/GO_0003713) (transcription coactivator activity), [GO:0003714](http://purl.obolibrary.org/obo/GO_0003714) (transcription corepressor activity), [GO:0043066](http://purl.obolibrary.org/obo/GO_0043066) (negative regulation of apoptotic process), [GO:0030510](http://purl.obolibrary.org/obo/GO_0030510) (regulation of BMP signaling pathway), [GO:0010960](http://purl.obolibrary.org/obo/GO_0010960) (magnesium ion homeostasis), 

**Class expressions from DL-Learner:**

- [GO:0043027](http://purl.obolibrary.org/obo/GO_0043027) (cysteine-type endopeptidase inhibitor activity involved in apoptotic process) 54.17%
- [GO:0003714](http://purl.obolibrary.org/obo/GO_0003714) (transcription corepressor activity) 54.17%
- [GO:0003712](http://purl.obolibrary.org/obo/GO_0003712) (transcription cofactor activity) 54.17%
- [GO:0001191](http://purl.obolibrary.org/obo/GO_0001191) (transcriptional repressor activity, RNA polymerase II transcription factor binding) 54.17%
- [GO:0001106](http://purl.obolibrary.org/obo/GO_0001106) (RNA polymerase II transcription corepressor activity) 54.17%
- [GO:0001104](http://purl.obolibrary.org/obo/GO_0001104) (RNA polymerase II transcription cofactor activity) 54.17%
- [GO:0043028](http://purl.obolibrary.org/obo/GO_0043028) (cysteine-type endopeptidase regulator activity involved in apoptotic process) and [GO:0061135](http://purl.obolibrary.org/obo/GO_0061135) (endopeptidase regulator activity) 54.17%
- [GO:0030414](http://purl.obolibrary.org/obo/GO_0030414) (peptidase inhibitor activity) and [GO:0043028](http://purl.obolibrary.org/obo/GO_0043028) (cysteine-type endopeptidase regulator activity involved in apoptotic process) 54.17%
- [GO:0004869](http://purl.obolibrary.org/obo/GO_0004869) (cysteine-type endopeptidase inhibitor activity) and [GO:0043028](http://purl.obolibrary.org/obo/GO_0043028) (cysteine-type endopeptidase regulator activity involved in apoptotic process) 54.17%
- [GO:0004866](http://purl.obolibrary.org/obo/GO_0004866) (endopeptidase inhibitor activity) and [GO:0043028](http://purl.obolibrary.org/obo/GO_0043028) (cysteine-type endopeptidase regulator activity involved in apoptotic process) 54.17%
- [GO:0004857](http://purl.obolibrary.org/obo/GO_0004857) (enzyme inhibitor activity) and [GO:0043028](http://purl.obolibrary.org/obo/GO_0043028) (cysteine-type endopeptidase regulator activity involved in apoptotic process) 54.17%
- [GO:0001191](http://purl.obolibrary.org/obo/GO_0001191) (transcriptional repressor activity, RNA polymerase II transcription factor binding) and [GO:0003714](http://purl.obolibrary.org/obo/GO_0003714) (transcription corepressor activity) 54.17%
- [GO:0001191](http://purl.obolibrary.org/obo/GO_0001191) (transcriptional repressor activity, RNA polymerase II transcription factor binding) and [GO:0003712](http://purl.obolibrary.org/obo/GO_0003712) (transcription cofactor activity) 54.17%
- [GO:0001104](http://purl.obolibrary.org/obo/GO_0001104) (RNA polymerase II transcription cofactor activity) and [GO:0003714](http://purl.obolibrary.org/obo/GO_0003714) (transcription corepressor activity) 54.17%
- [GO:0001104](http://purl.obolibrary.org/obo/GO_0001104) (RNA polymerase II transcription cofactor activity) and [GO:0001191](http://purl.obolibrary.org/obo/GO_0001191) (transcriptional repressor activity, RNA polymerase II transcription factor binding) 54.17%


